BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rao K, Malani PN. Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020. JAMA 2020;323:1403-4. [PMID: 32150234 DOI: 10.1001/jama.2019.3849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 O’grady K, Knight DR, Riley TV. Antimicrobial resistance in Clostridioides difficile. Eur J Clin Microbiol Infect Dis. [DOI: 10.1007/s10096-021-04311-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wu Z, Xu Q, Gu S, Chen Y, Lv L, Zheng B, Wang Q, Wang K, Wang S, Xia J, Yang L, Bian X, Jiang X, Zheng L, Li L. Akkermansia muciniphila Ameliorates Clostridioides difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Front Microbiol 2022;13:841920. [DOI: 10.3389/fmicb.2022.841920] [Reference Citation Analysis]
3 Sharma S, Weissman S, Walradt T, Aziz M, Vohra I, Acharya A, Sotiriadis J, Feuerstein JD, Tabibian JH. Readmission, healthcare consumption, and mortality in Clostridioides difficile infection hospitalizations: a nationwide cohort study. Int J Colorectal Dis 2021. [PMID: 34363511 DOI: 10.1007/s00384-021-04001-w] [Reference Citation Analysis]
4 Granata G, Mariotti D, Ascenzi P, Petrosillo N, di Masi A. High Serum Levels of Toxin A Correlate with Disease Severity in Patients with Clostridioides difficile Infection. Antibiotics (Basel) 2021;10:1093. [PMID: 34572675 DOI: 10.3390/antibiotics10091093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, Albuquerque A, Allocca M, Esteve M, Farraye FA, Gordon H, Karmiris K, Kopylov U, Kirchgesner J, MacMahon E, Magro F, Maaser C, de Ridder L, Taxonera C, Toruner M, Tremblay L, Scharl M, Viget N, Zabana Y, Vavricka S. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 2021;15:879-913. [PMID: 33730753 DOI: 10.1093/ecco-jcc/jjab052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
6 Kiersnowska ZM, Lemiech-Mirowska E, Semczuk K, Michałkiewicz M, Sierocka A, Marczak M. Level of Knowledge of Medical Staff on the Basis of the Survey in Terms of Risk Management, Associated with Clostridioides difficile Infections. Int J Environ Res Public Health 2021;18:7060. [PMID: 34280996 DOI: 10.3390/ijerph18137060] [Reference Citation Analysis]
7 Girleanu I, Trifan A, Huiban L, Muzica C, Nemteanu R, Teodorescu A, Singeap AM, Cojocariu C, Chiriac S, Petrea O, Zenovia S, Nastasa R, Cuciureanu T, Stanciu C. The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis-A Real Life Cohort. Medicina (Kaunas) 2021;57:964. [PMID: 34577887 DOI: 10.3390/medicina57090964] [Reference Citation Analysis]